欧洲细胞系开发市场至 2027 年 - 按类型(原代细胞系、杂交瘤、连续细胞系和重组细胞系)进行区域分析和预测;按产品(设备和介质及试剂);应用(药物发现、生物生产和组织工程);和地理

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 114    |    Report Code: TIPRE00009032    |    Category: Life Sciences

Europe Cell Line Development Market

市场介绍

细胞系是建立的细胞培养物,当提供生长培养基和生长空间。不同的细胞可以产生不同的细胞系。细胞系在细胞学研究中起着至关重要的作用。该细胞系能够在定制环境下逐步改变细胞的结构、生理学和基因组成。

市场概况和动态

欧洲细胞系开发市场预计将从 2019 年的 12.1401 亿美元增至 2027 年的 31.8757 亿美元。预计该市场的复合年增长率为2020 年至 2027 年为 13.0%。该市场的增长预计将由于政府对细胞系开发市场的参与不断增加以及生物技术行业的发展热潮等关键驱动因素而增长。然而,由于细胞系受到微生物污染,市场增长可能会受到阻碍。

关键细分市场

根据类型,细胞系开发市场分为原代细胞系、杂交瘤、连续细胞系和重组细胞系。根据产品,细胞系开发市场分为设备、媒体和设备。根据应用,细胞系开发市场分为药物发现、生物生产和组织工程。

主要来源和上市公司

u>

报告中包含的细胞系开发市场的一些主要主要和次要来源包括英国干细胞基金会、欧洲工业生物技术和生物经济论坛 (EFIB)生物技术和生物科学研究委员会 (BBSRC)< /p>

购买报告的理由

  • 了解欧洲细胞系开发市场格局并确定最有可能保证丰厚回报的细分市场
  • < li class=\"MsoNormalCxSpMiddle\">了解细胞系开发市场不断变化的竞争格局,保持领先地位
  • 高效规划并购;A 和合作伙伴通过确定最有希望销售的细分市场来涉足欧洲细胞系开发市场
  • 帮助通过敏锐和全面的洞察力做出明智的业务决策各细分市场Formcell生产线开发市场的市场表现分析
  • 获取欧洲地区2019年至2027年各细分市场的市场收入预测

EUROPECELL 系列开发市场细分

按类型

  • 原代细胞系
  • 杂交瘤
  • 连续细胞系
  • 重组细胞系

按产品

  • < span>设备
  • 媒体与设备试剂

按应用

  • 药物发现
  • 生物生产
  • 组织工程

按国家/地区

< ul>
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • < li>欧洲其他地区

     

    < strong>公司简介

    • 默克公司
    • Thermo Fisher Scientific, Inc.
    • SELEXIS
    • WuXiAppTec
    • 通用电气
    • 龙沙
    • 康宁公司


    Europe Cell Line Development Strategic Insights

    Strategic insights for Europe Cell Line Development involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/europe-cell-line-development-market-strategic-framework.webp
    Get more information on this report

    Europe Cell Line Development Report Scope

    Report Attribute Details
    Market size in 2019 US$ 1,214.01 Million
    Market Size by 2027 US$ 3,187.57 Million
    Global CAGR (2020 - 2027) 13.0%
    Historical Data 2017-2018
    Forecast period 2020-2027
    Segments Covered By 类型
    • 原代细胞系
    • 杂交瘤
    • 连续细胞系
    • 重组细胞系
    By 产品
    • 设备
    • 培养基及试剂
    By 应用
    • 药物研发
    • 生物生产和组织工程
    Regions and Countries Covered 欧洲
    • 英国
    • 德国
    • 法国
    • 俄罗斯
    • 意大利
    • 欧洲其他地区
    Market leaders and key company profiles
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • SELEXIS
  • WuXiAppTec
  • General Electric
  • Lonza
  • Corning Incorporated
  • Get more information on this report

    Europe Cell Line Development Regional Insights

    The regional scope of Europe Cell Line Development refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-cell-line-development-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Cell Line Development Market

    1. Merck KGaA
    2. Thermo Fisher Scientific, Inc.
    3. SELEXIS
    4. WuXiAppTec
    5. General Electric
    6. Lonza
    7. Corning Incorporated
    Frequently Asked Questions
    How big is the Europe Cell Line Development Market?

    The Europe Cell Line Development Market is valued at US$ 1,214.01 Million in 2019, it is projected to reach US$ 3,187.57 Million by 2027.

    What is the CAGR for Europe Cell Line Development Market by (2020 - 2027)?

    As per our report Europe Cell Line Development Market, the market size is valued at US$ 1,214.01 Million in 2019, projecting it to reach US$ 3,187.57 Million by 2027. This translates to a CAGR of approximately 13.0% during the forecast period.

    What segments are covered in this report?

    The Europe Cell Line Development Market report typically cover these key segments-

  • 类型 (原代细胞系, 杂交瘤, 连续细胞系, 重组细胞系)
  • 产品 (设备, 培养基及试剂)
  • 应用 (药物研发, 生物生产和组织工程)
  • What is the historic period, base year, and forecast period taken for Europe Cell Line Development Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Cell Line Development Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Europe Cell Line Development Market?

    The Europe Cell Line Development Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • SELEXIS
  • WuXiAppTec
  • General Electric
  • Lonza
  • Corning Incorporated
  • Who should buy this report?

    The Europe Cell Line Development Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Cell Line Development Market value chain can benefit from the information contained in a comprehensive market report.